ABWIX | FBCIX | ABWIX / FBCIX | |
Total Expense Ratio | 0.84 | 0.36 | 233% |
Annual Report Gross Expense Ratio | 0.85 | 0.36 | 236% |
Fund Existence | 20 years | 5 years | - |
Gain YTD | 9.073 | 14.224 | 64% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 427M | 117B | 0% |
Annual Yield % from dividends | 3.06 | 3.21 | 95% |
Returns for 1 year | 12.89 | 15.23 | 85% |
Returns for 3 years | 27.05 | 37.29 | 73% |
Returns for 5 years | 22.93 | N/A | - |
Returns for 10 years | 41.03 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
THNR | 23.85 | 0.10 | +0.40% |
Amplify Weight Loss Drug & Treatment ETF | |||
JHI | 13.97 | 0.04 | +0.32% |
John Hancock Investors Trust Capital Stock | |||
VCRB | 77.09 | 0.17 | +0.22% |
Vanguard Core Bond ETF | |||
IBTK | 19.67 | 0.03 | +0.15% |
iShares iBonds Dec 2030 Term Trsry ETF | |||
BBIB | 98.43 | -0.24 | -0.24% |
JPMorgan BetaBuilders U.S.TrsBd3-10YrETF |